• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪肝脏、肾脏及全身的半乳糖清除率

Hepatic, renal, and total body galactose elimination in the pig.

作者信息

Winkler K, Henriksen J H, Tygstrup N

机构信息

Department of Clinical Physiology, Hvidovre Hospital, Denmark.

出版信息

Am J Physiol. 1993 Jul;265(1 Pt 1):G9-14. doi: 10.1152/ajpgi.1993.265.1.G9.

DOI:10.1152/ajpgi.1993.265.1.G9
PMID:8338175
Abstract

Galactose elimination capacity is used as a quantitative measure of liver function on the assumption that galactose elimination outside the liver is negligible or easily corrected for. The relationship between hepatic and extrahepatic removal of galactose was studied in anesthetized pigs during quasi-steady-state conditions by continuous infusion of galactose. The hepatic removal approximated a constant [maximal velocity = 585 +/- 41 mumol/min, Michaelis constant (Km) = 0.24 +/- 0.07 mmol/l, mean +/- SE, n = 20]. The renal removal was less than the amount filtered, showing maximal tubular reabsorption (Tm 178 +/- 3.0 mumol/min, Km 3.8 +/- 0.9 mmol/l, n = 20). Metabolic conversion of galactose in the kidney was not demonstrable. At all concentrations studied (0.4-5.8 mmol/l), total galactose elimination from the body exceeded the sum of hepatic and renal elimination by approximately 100 mumol/min, independent of the concentration. At blood concentrations usually used for clinical estimation of the galactose elimination capacity (approximately 4 mmol/l), hepatic removal in the pig accounted for 55% and renal removal for 30% of total removal; 15% of removal occurred in other organs. We conclude that estimation of the hepatic galactose elimination capacity from whole body elimination curves requires correction for renal removal of galactose.

摘要

半乳糖清除能力被用作肝功能的定量指标,其假设前提是肝脏外的半乳糖清除可忽略不计或易于校正。通过持续输注半乳糖,在麻醉猪的准稳态条件下研究了肝脏和肝脏外对半乳糖清除的关系。肝脏清除近似为常数[最大速度 = 585±41 μmol/min,米氏常数(Km)= 0.24±0.07 mmol/L,均值±标准误,n = 20]。肾脏清除小于滤过量,显示出最大肾小管重吸收(Tm 178±3.0 μmol/min,Km 3.8±0.9 mmol/L,n = 20)。未证实半乳糖在肾脏中的代谢转化。在所有研究浓度(0.4 - 5.8 mmol/L)下,机体总的半乳糖清除量超过肝脏和肾脏清除量之和约100 μmol/min,与浓度无关。在通常用于临床评估半乳糖清除能力的血浓度(约4 mmol/L)下,猪的肝脏清除占总清除量的55%,肾脏清除占30%;15%的清除发生在其他器官。我们得出结论,根据全身清除曲线估计肝脏半乳糖清除能力需要校正肾脏对半乳糖的清除。

相似文献

1
Hepatic, renal, and total body galactose elimination in the pig.猪肝脏、肾脏及全身的半乳糖清除率
Am J Physiol. 1993 Jul;265(1 Pt 1):G9-14. doi: 10.1152/ajpgi.1993.265.1.G9.
2
Hepatic galactose elimination kinetics in the intact pig.完整猪肝脏中半乳糖清除动力学
Scand J Clin Lab Invest. 1982 May;42(3):253-9.
3
Splanchnic galactose uptake in patients with cirrhosis during continuous infusion.肝硬化患者在持续输注过程中内脏对半乳糖的摄取
Clin Physiol. 1983 Apr;3(2):179-85. doi: 10.1111/j.1475-097x.1983.tb00689.x.
4
Galactose clearance measurements and liver blood flow.半乳糖清除率测量与肝血流量
Gastroenterology. 1988 Feb;94(2):477-81. doi: 10.1016/0016-5085(88)90440-4.
5
Galactose removal kinetics during hypoxia in perfused pig liver: reduction of Vmax, but not of intrinsic clearance Vmax/Km.灌注猪肝缺氧时半乳糖清除动力学:Vmax降低,但内在清除率Vmax/Km未降低。
Eur J Clin Invest. 1990 Jun;20(3):305-9. doi: 10.1111/j.1365-2362.1990.tb01860.x.
6
Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver.离体灌注猪肝消除半乳糖的米氏动力学
Am J Physiol. 1976 May;230(5):1302-13. doi: 10.1152/ajplegacy.1976.230.5.1302.
7
Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model.使用2-[¹⁸F]氟-2-脱氧-D-半乳糖PET/CT测定肝脏半乳糖清除能力:该方法在正常猪肝模型中的可重复性及代谢异质性
Scand J Gastroenterol. 2011 Jan;46(1):98-103. doi: 10.3109/00365521.2010.510574. Epub 2010 Aug 9.
8
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.在实质肝疾病患者中,半乳糖类似物 2-18F-氟-2-脱氧-D-半乳糖的团集常数增加。
J Nucl Med. 2014 Apr;55(4):590-4. doi: 10.2967/jnumed.113.125559. Epub 2014 Mar 3.
9
Species differences of galactose metabolism in erythrocytes.
Scand J Clin Lab Invest. 1985 Dec;45(8):697-700. doi: 10.1080/00365518509155282.
10
Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.半乳糖的肝脏摄取和代谢可通过2-[18F]氟-2-脱氧半乳糖正电子发射断层扫描在体内进行定量分析。
Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G27-G36. doi: 10.1152/ajpgi.00004.2008. Epub 2008 May 15.

引用本文的文献

1
Modelling severe Staphylococcus aureus sepsis in conscious pigs: are implications for animal welfare justified?清醒猪严重金黄色葡萄球菌败血症模型:对动物福利的影响是否合理?
BMC Res Notes. 2016 Feb 16;9:99. doi: 10.1186/s13104-016-1888-7.
2
Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model.使用2-[¹⁸F]氟-2-脱氧-D-半乳糖PET/CT测定肝脏半乳糖清除能力:该方法在正常猪肝模型中的可重复性及代谢异质性
Scand J Gastroenterol. 2011 Jan;46(1):98-103. doi: 10.3109/00365521.2010.510574. Epub 2010 Aug 9.
3
Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.
半乳糖的肝脏摄取和代谢可通过2-[18F]氟-2-脱氧半乳糖正电子发射断层扫描在体内进行定量分析。
Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G27-G36. doi: 10.1152/ajpgi.00004.2008. Epub 2008 May 15.